Propanc Biopharma, Inc. Quarterly Depreciation in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Propanc Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q3 2011 to Q2 2024.
  • Propanc Biopharma, Inc. Depreciation for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Propanc Biopharma, Inc. Depreciation for the twelve months ending June 30, 2024 was $297.000, a 82.2% decline year-over-year.
  • Propanc Biopharma, Inc. annual Depreciation for 2024 was $297.000, a 82.2% decline from 2023.
  • Propanc Biopharma, Inc. annual Depreciation for 2023 was $1.67K, a 16.5% decline from 2022.
  • Propanc Biopharma, Inc. annual Depreciation for 2022 was $1.99K, unchanged from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $297 $0 -$320 -100% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-30
Q1 2024 $617 $49.00 -$401 -89.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.02K $114 -$308 -73% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 $1.33K $134 -$339 -71.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.67K $320 -$170 -34.7% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 $1.84K $450 -$40 -8.16% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.88K $422 -$82 -16.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 $1.96K $473 -$36 -7.07% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.99K $490 -$36 -6.84% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 $2.03K $490 -$33 -6.31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.06K $504 -$2 -0.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 $2.06K $509 +$71.00 +16.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.99K $526 -$88 -14.3% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 $2.08K $523 -$66 -11.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $2.15K $506 -$128 -20.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $2.28K $438 -$198 -31.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.47K $614 Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 $589 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $634 Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 $636 +$107 +20.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q3 2018 $529 -$42 -7.36% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q3 2017 $571 +$22.00 +4.01% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q3 2016 $549 +$378 +221% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q3 2015 $171 +$171 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q3 2014 $0 -$258 -100% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q3 2013 $258 -$111 -30.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q3 2012 $369 -$148 -28.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q3 2011 $517 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.